Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMmotion150: Atezolizumab +/- Bevacizumab vs Sunitinib in Advanced RCC
NCT01984242Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2014
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of atezolizumab in renal cell carcinoma (RCC), sponsored by Roche. Started Jan 2014; status: completed.
02
Drugs
atezolizumab
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01984242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984242.